114 related articles for article (PubMed ID: 8581394)
1. Interleukin-1 alpha and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSF.
Gautier V; Pujol JL; Michel FB
Lung Cancer; 1995 Oct; 13(2):145-53. PubMed ID: 8581394
[TBL] [Abstract][Full Text] [Related]
2. Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma.
Hamm J; Schiller JH; Cuffie C; Oken M; Fisher RI; Shepherd F; Kaiser G
J Clin Oncol; 1994 Dec; 12(12):2667-76. PubMed ID: 7989942
[TBL] [Abstract][Full Text] [Related]
3. Effect of rhGM-CSF on haematopoietic reconstitution after chemotherapy in small-cell lung cancer.
Havemann K; Klausmann M; Wolf M; Fischer JR; Drings P; Oster W
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S203-7. PubMed ID: 1665493
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.
Shitara T; Yugami S; Ijima H; Sotomatu M; Kuroume T
Am J Hematol; 1994 Jan; 45(1):58-62. PubMed ID: 7504401
[TBL] [Abstract][Full Text] [Related]
5. Results of a dose-intense phase 1 study of a combination chemotherapy regimen with cisplatin and epidoxorubicin including medroxyprogesterone acetate and recombinant interleukin-2 in patients with inoperable primary lung cancer.
Mantovani G; Macciò A; Lai P; Massa E; Massa D; Mulas C; Succu G; Mudu MC; Manca G; Versace R; Pisano A
J Immunother; 2000; 23(2):267-74. PubMed ID: 10746553
[TBL] [Abstract][Full Text] [Related]
6. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
Pujol JL; Douillard JY; Rivière A; Quoix E; Lagrange JL; Berthaud P; Bardonnet-Comte M; Polin V; Gautier V; Milleron B; Chomy F; Chomy P; Spaeth D; Le Chevalier T
J Clin Oncol; 1997 May; 15(5):2082-9. PubMed ID: 9164221
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
Shi YK; Sun Y; Su M
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):356-9. PubMed ID: 7895587
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
Bunn PA; Crowley J; Kelly K; Hazuka MB; Beasley K; Upchurch C; Livingston R; Weiss GR; Hicks WJ; Gandara DR
J Clin Oncol; 1995 Jul; 13(7):1632-41. PubMed ID: 7602352
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor.
Riccardi A; Danova M; Paccagnella A; Giordano M; Favaretto A; Panozzo M; Ghiotto C; Comis S; Fiorentino M; Chieco-Bianchi L
Ann Hematol; 1993 Apr; 66(4):185-93. PubMed ID: 8387346
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial.
Bajorin DF; Nichols CR; Schmoll HJ; Kantoff PW; Bokemeyer C; Demetri GD; Einhorn LH; Bosl GJ
J Clin Oncol; 1995 Jan; 13(1):79-86. PubMed ID: 7799046
[TBL] [Abstract][Full Text] [Related]
11. Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor.
Gatti E; Scagliotti GV; Ferrari G; Mutti L; Pozzi E; Stacchini A; Fubini L; Aglietta M
Eur Respir J; 1995 Sep; 8(9):1566-71. PubMed ID: 8575586
[TBL] [Abstract][Full Text] [Related]
12. Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.
Engelhard M; Gerhartz H; Brittinger G; Engert A; Fuchs R; Geiseler B; Gerhartz D; Haunauske AR; Hartlapp HJ; Huhn D
Ann Oncol; 1994; 5 Suppl 2():123-5. PubMed ID: 7515644
[TBL] [Abstract][Full Text] [Related]
13. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
Woll PJ; Hodgetts J; Lomax L; Bildet F; Cour-Chabernaud V; Thatcher N
J Clin Oncol; 1995 Mar; 13(3):652-9. PubMed ID: 7533825
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot study.
Bergmann L; Karakas T; Knuth A; Lautenschläger G; Mitrou PS; Hoelzer D
Eur J Cancer; 1995 Dec; 31A(13-14):2164-8. PubMed ID: 8652236
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer.
Eguchi K; Kabe J; Kudo S; Mano K; Morinari H; Nakada K; Noda K; Saito Y; Tanaka T; Uzawa T
Cancer Chemother Pharmacol; 1994; 34(1):37-43. PubMed ID: 8174201
[TBL] [Abstract][Full Text] [Related]
16. Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor.
Gurney H; Anderson H; Radford J; Potter MR; Swindell R; Steward W; Kamthan A; Chang J; Weiner J; Thatcher N
Eur J Cancer; 1992; 28(1):105-12. PubMed ID: 1314626
[TBL] [Abstract][Full Text] [Related]
17. Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma.
Ho AD; Haas R; Wulf G; Knauf W; Ehrhardt R; Heilig B; Körbling M; Schulz G; Hunstein W
Blood; 1990 Jan; 75(1):203-12. PubMed ID: 2104762
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas.
Hovgaard D; Nissen NI
Leuk Lymphoma; 1992 Jun; 7(3):217-24. PubMed ID: 1477649
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
[TBL] [Abstract][Full Text] [Related]
20. Circulating myeloid progenitor cell kinetics during hematologic recovery from chemotherapy and subsequent recombinant human granulocyte-macrophage colony-stimulating factor administration.
Ventura GJ; Reading CL; Hester JP; Vadhan-Raj S
Acta Haematol; 1990; 84(4):175-81. PubMed ID: 2125781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
